|
This is an index of adverse event reports related to Fluorouracil. Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the adverse reaction. Or scroll down to view a sample of recent reports further on this page.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (530)
Cases resulting in a serious event (505)
Cases resulting in death (100)
Cases resulting in life threatening events (40)
Cases resulting in hospitalization (334)
Cases resulting in disability (9)
Cases resulting in other serious reactions (140)
Below is a sample of adverse event reports reports related to Fluorouracil. For a complete list and/or a specific selection of reports, please use the links in the index above.
Adverse event in male receiving Fluorouracil
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-31
Patient: male, weighing 100.9 kg (222.0 pounds)
Adverse reactions / side effects: Oral Intake Reduced, Clostridium Difficile Colitis
Adverse event resulted in: hospitalization
Suspect drug(s):
Cisplatin
Dosage: 150mg iv
Indication: Neoplasm Malignant
Start date: 2007-08-23
Fluorouracil
Dosage: 1500mg bid iv qd
Indication: Neoplasm Malignant
Start date: 2007-08-23
End date: 2007-08-27
Taxotere
Dosage: 150mg iv
Indication: Neoplasm Malignant
Start date: 2007-08-23
Other drugs received by patient: Ambien; Aspirin; Ativan; Compazine; Hyzaar; Lidex; Lipitor; Loprox; Nasonex; Singulair; Zofran
Adverse event in female receiving Fluorouracil
Reported by a consumer/non-health professional from United Kingdom on 2007-10-31
Patient: female, weighing 61.5 kg (135.3 pounds)
Adverse reactions / side effects: Vomiting, Diarrhoea, Hypokalaemia
Adverse event resulted in: hospitalization
Suspect drug(s):
Bevacizumab
Dosage: 326 mg, q2w
Indication: Colon Cancer
Start date: 2007-04-04
Fluorouracil
Dosage: 650 mg, q2w
Start date: 2007-04-04
Leucovorin
Dosage: 320 mg, q2w
Indication: Colon Cancer
Start date: 2007-04-04
Oxaliplatin
Dosage: 137 mg, q2w
Indication: Colon Cancer
Start date: 2007-04-04
Other drugs received by patient: Rabeprazole Sodium; Zofran; Prochlorperazine; Aluminum Hydroxide Gel; Norvasc; Bisoprolol Fumarate; Ramipril
Adverse event in male receiving Fluorouracil
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-31
Patient: male, weighing 100.9 kg (222.0 pounds)
Adverse reactions / side effects: Syncope Vasovagal, Arteriospasm Coronary, Cardiac Disorder
Adverse event resulted in: hospitalization
Suspect drug(s):
Cisplatin
Dosage: 150mg iv
Indication: Neoplasm Malignant
Start date: 2007-08-23
Fluorouracil
Dosage: 1500mg bid iv qd
Indication: Neoplasm Malignant
Start date: 2007-08-23
End date: 2007-08-27
Taxotere
Dosage: 150mg iv
Indication: Neoplasm Malignant
Start date: 2007-08-23
Other drugs received by patient: Ambien; Aspirin; Ativan; Compazine; Hyzaar; Lidex; Lipitor; Loprox; Nasonex; Singulair; Zofran
Adverse event in 77 year old male receiving Fluorouracil
Reported by a physician from Germany on 2007-10-31
Patient: 77 year old male
Adverse reactions / side effects: Nephrotic Syndrome, Renal Failure Acute
Adverse event resulted in: hospitalization
Suspect drug(s):
Erbitux
Indication: Colon Cancer
Start date: 2006-08-10
End date: 2007-02-13
Fluorouracil
Dosage: no.of dosage=d1+d2
Indication: Colon Cancer
Start date: 2005-07-19
End date: 2007-02-13
Irinotecan HCL
Indication: Colon Cancer
Start date: 2005-07-19
End date: 2007-02-13
Leucovorin
Dosage: no.of dosage=d1+d2
Indication: Colon Cancer
Start date: 2005-07-19
End date: 2007-02-13
Other drugs received by patient: Penmix
Adverse event in male receiving Fluorouracil
Reported by a individual with unspecified qualification from United States on 2007-10-31
Patient: male, weighing 69.1 kg (152.0 pounds)
Adverse reactions / side effects: Fatigue, Vomiting, Nausea, Rectal Tenesmus, Proctalgia
Adverse event resulted in: hospitalization
Suspect drug(s):
Bevacizumab(rhumab Vegf)
Dosage: 1130 mg
End date: 2007-09-11
Eloxatin
Dosage: 479 mg
End date: 2007-09-11
Fluorouracil
Dosage: 12632 mg
End date: 2007-09-11
Leucovorin Calcium
Dosage: 2256 mg
End date: 2007-09-11
Adverse event in female receiving Fluorouracil
Reported by a physician from Egypt on 2007-10-30
Patient: female, weighing 65.0 kg (143.0 pounds)
Adverse reactions / side effects: Pneumonia, Pancytopenia
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Fluorouracil
Dosage: 400 mg/m2 bolus followed by 600 mg/m2 infusion
Start date: 2006-12-18
End date: 2006-12-19
Leucovorin
Start date: 2006-12-18
End date: 2006-12-19
Oxaliplatin
Indication: Colon Cancer
Start date: 2006-12-18
End date: 2006-12-18
Adverse event in female receiving Fluorouracil
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-30
Patient: female, weighing 80.3 kg (176.7 pounds)
Adverse reactions / side effects: Pancytopenia, Splenomegaly
Suspect drug(s):
Eloxatin
Dosage: 85 mg/m2 every 2 weeks
Indication: Colon Cancer
Start date: 2006-02-07
End date: 2006-02-07
Fluorouracil
Dosage: 500 mg/m2 every week
Indication: Colon Cancer
Start date: 2006-02-07
End date: 2006-02-07
Leucovorin Calcium
Dosage: 500 mg/m2 every week
Indication: Colon Cancer
Start date: 2006-02-07
End date: 2006-02-07
Other drugs received by patient: Lomotil; Compazine; Iron Pill; Prozac
Adverse event in male receiving Fluorouracil
Reported by a individual with unspecified qualification from United States on 2007-10-29
Patient: male, weighing 79.1 kg (174.0 pounds)
Adverse reactions / side effects: Type IV Hypersensitivity Reaction
Adverse event resulted in: hospitalization
Suspect drug(s):
Bevacizumab (Rhumab Vegf)
Dosage: 387 mg
End date: 2007-10-24
Eloxatin
Dosage: 47 mg
End date: 2007-10-24
Fluorouracil
Dosage: 5180 mg
End date: 2007-10-24
Leucovorin Calcium
Dosage: 740 mg
End date: 2007-10-24
Adverse event in male receiving Fluorouracil
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-29
Patient: male, weighing 175.0 kg (385.0 pounds)
Adverse reactions / side effects: Hepatic Failure, Disease Progression
Adverse event resulted in: hospitalization
Suspect drug(s):
Aranesp
Dosage: 200 a?g, prn
Indication: Anaemia
Avastin
Dosage: 590 mg, unk
Indication: Metastatic Neoplasm
Start date: 2005-07-18
End date: 2005-08-02
Fluorouracil
Dosage: 1140 mg, unk
Indication: Metastatic Neoplasm
Start date: 2005-07-18
End date: 2005-07-20
Fluorouracil
Dosage: 760 mg, unk
Start date: 2005-08-02
End date: 2005-08-03
Fluorouracil
Dosage: 1140 mg, unk
Start date: 2005-08-02
End date: 2005-08-04
Leucovorin
Dosage: 380 mg, unk
Indication: Metastatic Neoplasm
Start date: 2005-07-18
End date: 2005-08-03
Oxaliplatin
Dosage: 160 mg, unk
Indication: Metastatic Neoplasm
Start date: 2005-07-18
End date: 2005-08-02
Adverse event in female receiving Fluorouracil
Reported by a individual with unspecified qualification from United States on 2007-10-29
Patient: female, weighing 52.7 kg (115.9 pounds)
Adverse reactions / side effects: Oral Intake Reduced, Intestinal Obstruction, Thirst
Adverse event resulted in: hospitalization
Suspect drug(s):
Bevacizumab (Rhumab Vegf)
Dosage: 264 mg
End date: 2007-10-10
Eloxatin
Dosage: 128 mg
End date: 2007-10-10
Fluorouracil
Dosage: 4200 mg
End date: 2007-10-12
Leucovorin Calcium
Dosage: 600 mg
End date: 2007-10-10
Adverse event in male receiving Fluorouracil
Reported by a consumer/non-health professional from United Kingdom on 2007-10-26
Patient: male
Adverse reactions / side effects: Pancytopenia, Septic Shock
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Avastin
Dosage: 275 mg, unk
Indication: Colorectal Cancer
Start date: 2006-07-10
End date: 2006-07-10
Camptosar
Dosage: 300 mg, unk
Indication: Colorectal Cancer
Start date: 2006-07-10
End date: 2006-07-10
Fluorouracil
Dosage: 4600 mg, unk
Indication: Colorectal Cancer
Start date: 2006-07-10
End date: 2006-07-10
Folinic Acid
Indication: Drug USE FOR Unknown Indication
Start date: 2006-07-10
End date: 2006-07-10
Adverse event in 71 year old male receiving Fluorouracil
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-26
Patient: 71 year old male
Adverse reactions / side effects: Burning Sensation, Pruritus, Rash Maculo-Papular
Suspect drug(s):
Eloxatin
Dosage: 166 mg
Fluorouracil
Dosage: 780mg bolus/4680mg over 46?
Start date: 2007-10-03
Other drugs received by patient: Leucovorin; Zofran; Decadron
Adverse event in female receiving Fluorouracil
Reported by a individual with unspecified qualification from United States on 2007-10-26
Patient: female, weighing 75.7 kg (166.5 pounds)
Adverse reactions / side effects: Neutropenia
Suspect drug(s):
Eloxatin
Dosage: 150 mg
Fluorouracil
Dosage: 4970 mg
Leucovorin Calcium
Dosage: 700 mg
Adverse event in male receiving Fluorouracil
Reported by a physician from Germany on 2007-10-26
Patient: male
Adverse reactions / side effects: Hepatic Function Abnormal, Diarrhoea, Sepsis, Dehydration, Gastrointestinal Inflammation, Circulatory Collapse, Bronchitis
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Eloxatin
Indication: Gastric Cancer
Start date: 2007-08-01
End date: 2007-08-01
Fluorouracil
Indication: Gastric Cancer
Start date: 2007-08-01
End date: 2007-08-01
Folinic Acid
Indication: Gastric Cancer
Start date: 2007-08-01
End date: 2007-08-01
Other drugs received by patient: Fumaderm; Novalgin; Nexium
Adverse event in 59 year old female receiving Fluorouracil
Reported by a physician from Germany on 2007-10-25
Patient: 59 year old female
Adverse reactions / side effects: Deafness
Suspect drug(s):
Camptosar
Dosage: text:6-8 weeks
Indication: Small Intestine Carcinoma
Fluorouracil
Dosage: text:6-8 weeks
Indication: Small Intestine Carcinoma
Folinic Acid
Dosage: text:6-8 weeks
Indication: Small Intestine Carcinoma
Adverse event in 65 year old female receiving Fluorouracil
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-25
Patient: 65 year old female
Adverse reactions / side effects: Sudden Death
Adverse event resulted in: death
Suspect drug(s):
Eloxatin
Dosage: unk
Indication: Colon Cancer Metastatic
Start date: 2007-10-10
End date: 2007-10-10
Fluorouracil
Dosage: unk
Indication: Colon Cancer Metastatic
Leucovorin
Dosage: unk
Indication: Colon Cancer Metastatic
Start date: 2007-10-10
End date: 2007-10-10
Other drugs received by patient: Anzemet; Decadron
Adverse event in male receiving Fluorouracil
Reported by a individual with unspecified qualification from United States on 2007-10-25
Patient: male, weighing 73.4 kg (161.5 pounds)
Adverse reactions / side effects: Myocardial Ischaemia, Disease Progression, Liver Disorder, Drug Toxicity, Fatigue, Diarrhoea, Myocardial Infarction, Feeling Abnormal
Suspect drug(s):
Bevacizumab (Rhumab Vegf)
Dosage: 1411 mg
End date: 2007-09-04
Camptosar
Dosage: 707 mg
End date: 2007-09-04
Fluorouracil
Dosage: 9615 mg
End date: 2007-09-04
Leucovorin Calcium
Dosage: 2828 mg
End date: 2007-09-04
Adverse event in male receiving Fluorouracil
Reported by a individual with unspecified qualification from United States on 2007-10-25
Patient: male, weighing 105.9 kg (233.0 pounds)
Adverse reactions / side effects: Pulmonary Embolism
Suspect drug(s):
Bevacizumab (Rhumab Vegf)
Dosage: 2100 mg
End date: 2007-10-15
Camptosar
Dosage: 1360 mg
End date: 2007-10-15
Fluorouracil
Dosage: 20000 mg
End date: 2007-10-17
Leucovorin Calcium
Dosage: 3640 mg
End date: 2007-10-15
Adverse event in female receiving Fluorouracil
Reported by a physician from United Kingdom on 2007-10-25
Patient: female, weighing 137.8 kg (303.2 pounds)
Adverse reactions / side effects: Abdominal Pain, Vomiting, Pyrexia
Adverse event resulted in: hospitalization
Suspect drug(s):
Bevacizumab
Dosage: 312.5 mg, q2w
Indication: Colon Cancer
Start date: 2007-04-23
Fluorouracil
Dosage: 660 mg, q2w
Indication: Colon Cancer
Start date: 2007-04-23
Leucovorin
Dosage: 660 mg, q2w
Indication: Colon Cancer
Start date: 2007-04-23
Oxaliplatin
Dosage: 140 mg, q2w
Indication: Colon Cancer
Start date: 2007-04-23
Other drugs received by patient: Neupogen; Modulon; Iron Supplement
Adverse event in female receiving Fluorouracil
Reported by a individual with unspecified qualification from United States on 2007-10-24
Patient: female, weighing 54.0 kg (118.8 pounds)
Adverse reactions / side effects: Febrile Neutropenia
Adverse event resulted in: hospitalization
Suspect drug(s):
Cisplatin
Dosage: 68 mg
Ellence
Dosage: 42 mg
Erbitux
Dosage: 1125 mg
Fluorouracil
Dosage: 6300 mg
Adverse event in female receiving Fluorouracil
Reported by a consumer/non-health professional from Australia on 2007-10-24
Patient: female
Adverse reactions / side effects: Osteonecrosis
Suspect drug(s):
Blinded Bevacizumab
Dosage: unk, q3w
Indication: Breast Cancer Metastatic
Start date: 2006-12-21
End date: 2007-09-04
Blinded Capecitabine
Dosage: unk, q3w
Indication: Breast Cancer Metastatic
Start date: 2006-12-21
End date: 2007-09-04
Blinded Docetaxel
Dosage: unk, q3w
Indication: Breast Cancer Metastatic
Start date: 2006-12-21
End date: 2007-09-04
Blinded NO Study Drug Administered
Dosage: unk, q3w
Indication: Breast Cancer Metastatic
Start date: 2006-12-21
End date: 2007-09-04
Blinded Paclitaxel
Dosage: unk, q3w
Indication: Breast Cancer Metastatic
Start date: 2006-12-21
End date: 2007-09-04
Blinded Placebo
Dosage: unk, q3w
Indication: Breast Cancer Metastatic
Start date: 2006-12-21
End date: 2007-09-04
Capecitabine
Dosage: 2500 mg, d1-14/q3w
Indication: Breast Cancer Metastatic
Start date: 2006-12-21
Cyclophosphamide
Dosage: unk, q3w
Indication: Breast Cancer Metastatic
Start date: 2006-12-21
End date: 2007-09-04
Doxorubicin HCL
Dosage: unk, q3w
Indication: Breast Cancer Metastatic
Start date: 2006-12-21
End date: 2007-09-04
Epirubicin
Dosage: unk, q3w
Indication: Breast Cancer Metastatic
Start date: 2006-12-21
End date: 2007-09-04
Fluorouracil
Dosage: unk, q3w
Indication: Breast Cancer Metastatic
Start date: 2006-12-21
End date: 2007-09-04
Other drugs received by patient: Zoledronic Acid; Perindopril Erbumine
Adverse event in male receiving Fluorouracil
Reported by a individual with unspecified qualification from United States on 2007-10-24
Patient: male, weighing 27.9 kg (61.4 pounds)
Adverse reactions / side effects: Cholecystitis Acute, Enterobacter Sepsis
Adverse event resulted in: hospitalization
Suspect drug(s):
Fluorouracil
Indication: Metastatic Neoplasm
Start date: 2007-08-07
End date: 2007-08-19
Fluorouracil
Irinotecan HCL
Indication: Metastatic Neoplasm
Leucovorin
Indication: Metastatic Neoplasm
Sutent
Dosage: daily dose:25mg-freq:1 daily
Administration route: Oral
Indication: Metastatic Neoplasm
Start date: 2007-08-08
End date: 2007-08-20
Adverse event in male receiving Fluorouracil
Reported by a individual with unspecified qualification from United States on 2007-10-24
Patient: male, weighing 69.1 kg (152.0 pounds)
Adverse reactions / side effects: Fatigue, Vomiting, Nausea, Proctalgia
Adverse event resulted in: hospitalization
Suspect drug(s):
Bevacizumab (Rhumab Vegf)
Dosage: 1130 mg
End date: 2007-09-11
Eloxatin
Dosage: 479 mg
End date: 2007-09-11
Fluorouracil
Dosage: 12632 mg
End date: 2007-09-11
Leucovorin Calcium
Dosage: 2256 mg
End date: 2007-09-11
Adverse event in female receiving Fluorouracil
Reported by a physician from United States on 2007-10-24
Patient: female
Adverse reactions / side effects: Asthenia
Adverse event resulted in: hospitalization
Suspect drug(s):
Fluorouracil
Irinotecan HCL
Leucovorin
Panitumumab
Indication: Colorectal Cancer
Start date: 2007-07-26
Panitumumab
Start date: 2007-08-14
End date: 2007-08-14
Other drugs received by patient: Synthroid; Wellbutrin
Adverse event in male receiving Fluorouracil
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-23
Patient: male, weighing 175.0 kg (385.0 pounds)
Adverse reactions / side effects: Abdominal Pain, Jaundice, Metastatic Neoplasm, Bile Duct Obstruction, Malignant Neoplasm Progression, Hepatic Failure, Oedema Peripheral, Abdominal Distension, Decreased Appetite, Lethargy
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Aranesp
Indication: Anaemia
Avastin
Indication: Metastatic Neoplasm
Start date: 2005-08-02
End date: 2005-08-02
Avastin
Dosage: unk
Fluorouracil
Indication: Metastatic Neoplasm
Start date: 2005-08-02
End date: 2005-08-04
Leucovorin
Indication: Metastatic Neoplasm
Start date: 2005-08-02
End date: 2005-08-03
Oxaliplatin
Indication: Metastatic Neoplasm
Start date: 2005-08-02
End date: 2005-08-02
|
